Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

IN-FACT

Financiado

INitiation FActor 3 as target in Cancer Therapy

Eukaryotic translation initiation is a process wherein ribosomal subunits are assembled by eukaryotic initiation factor (eIF) proteins. Mammalian eukaryotic translation initiation factor 3 (eIF3), consisting of the 13 subunits eIF... ver más

31/05/2027

UGOT - GOETEBORGS...

223K€

Presupuesto del proyecto: 223K€

Líder del proyecto

GOETEBORGS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-03-28

HORIZON-MSCA-2023-PF-01-01: MSCA Postdoctoral Fellowships 2023 ExpectedOutcome:Project results are expected to contribute to the following outcomes:

I+D

Cerrada hace 1 año

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

UGOT - GOETEBORGS UNIVERSITE...

222.73K€ | Lider

BUDAPEST UNIVERSITY OF TECHN...

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

BFU2017-85814-P BASES ESTRUCTURALES DE LA ACCION DE EIF3 Y OTROS FACTORES DE... 177K€ Cerrado

PID2019-106937RB-I00 HIF2 & NFE2L2, UNA APROXIMACION RACIONAL Y OTRA IMPARCIAL PA... 278K€ Cerrado

RTC2019-007227-1 AptaBreast: Desarrollo Preclínico de un Aptámero para el Tra... 285K€ Cerrado

BES-2010-037187 PROTEINAS ING Y SUPRESION TUMORAL 43K€ Cerrado

RTC-2017-6505-1 DESARROLLO DE UNA TERAPIA INNOVADORA PARA EL TRATAMIENTO DE... 576K€ Cerrado

PID2021-128722OB-I00 SUPERANDO LA RESISTENCIA A TERAPIAS ANTITUMORALES 472K€ Cerrado

Duración del proyecto: 38 meses Fecha Inicio: 2024-03-28
Fecha Fin: 2027-05-31

Líder del proyecto

GOETEBORGS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 223K€

Descripción del proyecto Eukaryotic translation initiation is a process wherein ribosomal subunits are assembled by eukaryotic initiation factor (eIF) proteins. Mammalian eukaryotic translation initiation factor 3 (eIF3), consisting of the 13 subunits eIF3a to eIF3m, is the largest and most complex eIF. Due to the emerging understanding of the role of eIF3 in a wide range of cancers, there is an increasing interest to examine its many subunits as potential therapeutic targets. Furthermore, interactions between subunit eIF3c and tumor suppressor protein schwannomin has been reported to promote development of the tumor neurofibromatosis 2 (NF2). Very few small molecule inhibitors reported targeting eIF3 subunits are reported, and are associated with high degree of uncertainty. There is hence a need to develop new and highly effective small molecules targeting the eIF3 subunits to be used in the treatment of cancer, as well as in the fundamental understanding of the interactions between the various subunits. The aim of this interdisciplinary project is to investigate the structures, dynamics, and interactions of subunits in the eIF3 family, and use this information to design, synthesize and test compounds for targeted cancer therapy. We will employ a range of computational and bioinformatics-based tools (protein-protein docking, molecular dynamics and metadynamics simulations, machine-learning based ligand design and docking techniques) to identify and explore key druggable interactions and regions in the initially targeted subunits eIF3a and c. To verify the inhibitory potential of the designed small molecules, chemical synthesis and in vitro evaluation will be performed. Through the combination of computational modeling, subunit-specific inhibition, and measurements of anticancer activity, we will be able to understand in more detail the mechanisms of action as well as interplay between different subunits, and the interactions between eIF3c and tumor suppressor protein schwannomin.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores